Health Care & Life Sciences » Pharmaceuticals | AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd. | Balance Sheet

Fiscal year is April-March. All values NZD Thousands.
2015
2016
2017
2018
2019
Cash & Short Term Investments
4,700.00
28,055.00
15,905.00
6,946.00
6,916
Total Accounts Receivable
10,536.00
15,472.00
14,017.00
14,779.00
16,278
Inventories
14,686.00
17,686.00
22,198.00
24,412.00
25,158
Other Current Assets
803.00
842.00
2,034.00
2,175.00
2,909
Total Current Assets
30,725.00
62,055.00
54,154.00
48,312.00
51,261
Net Property, Plant & Equipment
411.00
407.00
386.00
330.00
357
Total Investments and Advances
-
185.00
627.00
2,135.00
3,033
Intangible Assets
1,669.00
2,111.00
2,548.00
5,118.00
8,239
Total Assets
33,213.00
65,304.00
58,325.00
56,603.00
63,595
Accounts Payable
5,661.00
8,140.00
10,828.00
7,335.00
Income Tax Payable
-
-
112.00
118.00
Other Current Liabilities
4,792.00
5,773.00
4,489.00
11,154.00
Total Current Liabilities
10,453.00
13,913.00
15,429.00
18,607.00
Long-Term Debt
20,739.00
23,161.00
23,426.00
30,654.00
Deferred Taxes
408.00
546.00
610.00
708.00
Total Liabilities
31,192.00
37,074.00
38,855.00
49,261.00
Common Equity (Total)
10,830.00
28,230.00
19,470.00
7,342.00
Total Shareholders' Equity
2,021.00
28,230.00
19,470.00
7,342.00
Total Equity
2,021.00
28,230.00
19,470.00
7,342.00
Liabilities & Shareholders' Equity
33,213.00
65,304.00
58,325.00
56,603.00
Preferred Stock (Carrying Value)
12,851.00
-
-
-

About AFT Pharmaceuticals

View Profile
Address
Nielsen House
Auckland AU 0622
New Zealand
Employees -
Website http://www.aftpharm.com
Updated 07/08/2019
AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. Its feature brands include Crystaderm, Maxigesic, Coco-Scalp, Maxiclear, Eyecare Hub, and Allergy Hub. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World.